Core Viewpoint - United Imaging Healthcare has been awarded the first prize in the 2024 Shanghai Science and Technology Progress Award for its project on the independent research and industrialization of multimodal molecular imaging equipment, highlighting its technological advancements in the field [1][2]. Group 1: Project Achievements - The project focuses on multimodal molecular imaging systems, including PET/CT and PET/MR, which can non-invasively and accurately detect metabolic information in human tissues, aiding in the early detection and precise diagnosis of major diseases such as tumors and cardiovascular diseases [1]. - The project has achieved 13 national Class III medical device registrations and 12 certifications from the US FDA and EU CE, with over 600 molecular imaging devices installed globally across nearly 30 countries, including China, the US, Japan, Italy, Germany, and France [2]. Group 2: Clinical and Research Collaboration - The company has conducted extensive clinical application validation over the past decade, establishing a clinical and research application system that includes tumor imaging expert consensus and pharmacokinetic studies [3]. - The project has collaborated with ten well-known large hospitals in China, collecting over 40,000 clinical imaging cases for tumors using the world's first Total-body PET/CT uEXPLORER device, which has led to the development of personalized imaging and diagnostic solutions [3].